African health sciences · 2024
Sero-prevalence of Hepatitis B and C at a Primary Health Care Facility in Ghana.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Adanusa Madison, Adjei George, Eliason Sebastian, Amoah Samuel, Cecil Benson, Sirikyi Ignatius, Pappoe Faustina, Ofori Anasthasia, Adjei Frederick, Appau Bernice, Nyane Benjamin, Rudolf Arthur, Oheneba Hagan
Аннотация
BACKGROUND: The advent of emerging global infections such as SARS-CoV-2 has brought forth the public health crises of neglected diseases in the LMICs. Viral hepatitis infections remain a public health problem especially in the advent of emerging. Viral hepatitis which preponderantly afflicts citizens of LMICs is one such group of diseases which exerts considerable burden in these countries, especially, hepatitis B and C. There is an effective vaccine against Hepatitis B and curative treatment to hepatitis C, however, access has been hampered resulting in deleterious sequalae. Identifying population afflicted by these infections could lead to prevention of the complications.
MATERIALS AND METHODS: Retrospective review of electronic data on individuals screened for hepatitis B and C at the University of Cape Coast Hospital were abstracted. Data abstracted included hepatitis B and C test status, age, sex, previous immunisation history and region of residence. Overall prevalence and prevalence in different categories were calculated.
RESULTS: Data for 6,006 were collected and used for the analyses. The overall prevalence for hepatitis B in the study group was 5.06%. The prevalence for hepatitis C was 0.93%.
CONCLUSION: The burden of hepatitis B and C infection in Ghana is still high.
MATERIALS AND METHODS: Retrospective review of electronic data on individuals screened for hepatitis B and C at the University of Cape Coast Hospital were abstracted. Data abstracted included hepatitis B and C test status, age, sex, previous immunisation history and region of residence. Overall prevalence and prevalence in different categories were calculated.
RESULTS: Data for 6,006 were collected and used for the analyses. The overall prevalence for hepatitis B in the study group was 5.06%. The prevalence for hepatitis C was 0.93%.
CONCLUSION: The burden of hepatitis B and C infection in Ghana is still high.